Company maintains 3%-6% sales growth target despite flat organic sales in Q2 2026.
TriMas raised its 2026 adjusted earnings per share outlook to a range of $1.60-$1.70, citing continued profitability improvements. The company reported Q2 net sales of $174.6 million, up 1.6% year-over-year, though organic sales remained flat.
Management attributed the earnings growth to operational efficiencies, offsetting mixed end-market performance. The 3%-6% sales growth target for 2026 was reaffirmed, aligning with prior guidance. Comparable Q2 2025 net sales were not disclosed.
CEO Thomas Snyder highlighted strong earnings momentum but noted challenges in organic growth due to market offsets.